AI in Drug Discovery Market: North America Projected to Grow by 29.5% Annually till 2026, Despite the Impact of COVID-19

Dublin, June 29, 2020 (GLOBE NEWSWIRE) — The “North America Artificial Intelligence (AI) in Drug Discovery Market 2020-2026 by Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Country: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering.Market StructureGrowth DriversRestraints and ChallengesEmerging Product Trends & Market OpportunitiesPorter’s Fiver ForcesThe trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America AI in drug discovery market in every aspect of the classification from perspectives of Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Country.SoftwareServiceBased on technology, the North America market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.Deep LearningSupervised LearningReinforcement LearningUnsupervised LearningOther TechnologiesBased on drug type, the North America market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.Large-molecule DrugsSmall-molecular DrugsBased on therapeutic area, the North America market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.OncologyNeurodegenerative DiseasesCardiovascular DiseaseMetabolic DiseasesOther Therapeutic AreasBased on application, the North America market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.Information & Data AnalysisDrug DesignDrug EvaluationClinical TrialsOther ApplicationsBased on end user, the North America market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.Pharmaceutical & Biotechnology CompaniesAcademic & Research InstitutesContract Research OrganizationsGeographically, the following national/local markets are fully investigated:U.S.CanadaMexicoFor each of the aforementioned countries, detailed analysis and data for annual revenue are available for 2015-2026. The breakdown of key national markets by Technology, Therapeutic Area, and End User over the forecast years are also included.Atomwise, Inc.BenevolentAIBerg LLCBioageBIOAGECloud Pharmaceuticals, Inc.CyclicaDeep GenomicsEnvisagenicsExscientiaGoogleIBM CorporationInsilico MedicineMicrosoft CorporationNumedii, Inc.NumerateNVIDIA CorporationOwkin, Inc.Twoxar, IncorporatedVerge GenomicsXtalpi, Inc.For more information about this report visit https://www.researchandmarkets.com/r/u3929dResearch and Markets also offers Custom Research services providing focused, comprehensive and tailored research.CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900